Does EPA Lower CV Risk? REDUCE-IT Revisited : vimarsana.com

After years of controversy, both skeptics and proponents of the REDUCE-IT study findings agree that a new trial may be desirable, but unlikely to happen.

Related Keywords

New York , United States , Boston , Massachusetts , Canada , United Kingdom , American , Canadian , Paul Ridker , Deepak Bhatt , Jane Armitage , Deepakl Bhatt , Steven Nissen , Salims Virani , Vascular Institute , Us National Lipid Association , Mount Sinai Heart Center , Drug Administration , Harvard Medical School , American Diabetes Association , American Heart Association Scientific Sessions , Cardiovascular Research At Baylor College Of Medicine , Us Veterans Affairs , Us National Institutes Of Health , Clinical Trial Service Unit At Oxford University , Cleveland Clinic , Medscape Cardiology , New England Journal , Clinical Trials , Clinical Trial Service Unit , Oxford University , Cardiovascular Disease Prevention , Cardiovascular Research , Baylor College , Cv , Ardiovascular , Lipids , Ipid Management , Minerals , Biomarker , Iological Marker , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Fish Oil , Statin , Lipid Lowering Drugs , Rug Lipid Lowering , Atrial Fibrillation , F Atrial Fibrillation , Generics , Generic Drug , Eneric Medication , Heart , Triglycerides , Cardiovascular Disease , Vd C ,